BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp.

NASDAQ:BCTX

Overview | Financials
Company Name BriaCell Therapeutics Corp.
Symbol BCTX
Currency USD
Price 0.39
Market Cap 17,239,638
Dividend Yield 0%
52-week-range 0.38 - 4.61
Industry Biotechnology
Sector Healthcare
CEO Dr. William V. Williams M.D.
Website https://www.briacell.com

An error occurred while fetching data.

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and

Related Stocks

Journey Medical Corporation logo

Journey Medical Corporation

DERM

3.73 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.17 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.345 USD

Centogene N.V. logo

Centogene N.V.

CNTG

0.325 USD

Eyenovia, Inc. logo

Eyenovia, Inc.

EYEN

0.086 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

1.15 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0 USD

Financials

Numbers are in millions USD

Numbers are in millions USD